A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutationMarta Castroviejo‐Bermejo, Violeta Serra, Alejandra Bruna et al.|EMBO Molecular Medicine|2018Cited by 271
Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial)Christian Siso, Isabel T. Rubio, Juan de Torres et al.|Annals of Surgical Oncology|2017Cited by 132
Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patientsVicente Peg, Isabel T. Rubio, Martín Espinosa-Bravo et al.|Breast Cancer Research and Treatment|2013Cited by 105
Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular EntityAleix Prat, Javier Cortés, Bárbara Adamo et al.|Scientific Reports|2013Cited by 56